SYS1 inhibitors are a class of compounds designed to specifically target and inhibit the function of the SYS1 protein, which plays a role in intracellular trafficking and membrane protein localization. SYS1 is part of the Golgi-associated retrograde protein (GARP) complex, a crucial component involved in the retrograde transport of vesicles between the endosomes and the trans-Golgi network (TGN). This transport pathway is essential for the proper sorting and recycling of membrane proteins and lipids. SYS1 acts as a cargo adapter, facilitating the correct localization and function of proteins within the Golgi and endosomal compartments. Inhibitors of SYS1 function by disrupting its role in this vesicular transport process, thereby affecting the overall efficiency of protein sorting and membrane trafficking within the cell.
The chemical structures of SYS1 inhibitors vary, but their mechanisms generally involve blocking the interaction between SYS1 and its binding partners or substrates within the Golgi complex. Some inhibitors may bind directly to the SYS1 protein, preventing it from associating with other components of the GARP complex, while others may affect its conformation, reducing its ability to function as a cargo adapter. By inhibiting SYS1, these compounds interfere with the retrograde transport system, leading to disruptions in protein and lipid distribution within the cell. This, in turn, impacts the integrity and function of organelles like the Golgi apparatus and endosomes. Studying SYS1 inhibitors provides important insights into the molecular mechanisms of intracellular trafficking and highlights the specific role that SYS1 plays in maintaining cellular organization and homeostasis. Understanding the effects of SYS1 inhibition helps reveal broader principles of protein sorting and membrane dynamics in eukaryotic cells.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide decreases protein synthesis by inhibiting transcriptional activity, potentially reducing the expression of the SYS1 golgi trafficking protein. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, leading to a general decrease in mRNA synthesis, which would include mRNA of the SYS1 gene. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by blocking translocation, thus potentially preventing the production of the SYS1 golgi trafficking protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a pathway that controls protein synthesis; this could reduce the expression of the SYS1 protein. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II and thus mRNA synthesis, potentially decreasing SYS1 protein expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine disrupts lysosomal function and autophagy, which could non-specifically affect the turnover and expression of the SYS1 protein. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 inhibits proteasome, altering the degradation of proteins and possibly affecting the levels of SYS1 protein indirectly. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts Golgi function and could indirectly lower the expression of Golgi-related proteins such as SYS1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which could disrupt proper folding and stability of the SYS1 protein, leading to its reduced expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin causes premature chain termination during protein synthesis, potentially reducing the levels of SYS1 protein. | ||||||